388 results on '"Lalmanach, Gilles"'
Search Results
2. ProteoCure: A European network to fine-tune the proteome
3. Pharmacological inhibition of cathepsin S and of NSPs-AAP-1 (a novel, alternative protease driving the activation of neutrophil serine proteases)
4. Cathepsin V: Molecular characteristics and significance in health and disease
5. Binding of heparan sulfate to human cystatin C modulates inhibition of cathepsin L: Putative consequences in mucopolysaccharidosis
6. Upregulation of gut cathepsin L during Eimeria tenella infection
7. The abnormal accumulation of heparan sulfate in patients with mucopolysaccharidosis prevents the elastolytic activity of cathepsin V
8. Oxidation of cathepsin S by major chemicals of cigarette smoke
9. Rat cathepsin K: Enzymatic specificity and regulation of its collagenolytic activity
10. Imaging of extracellular cathepsin S activity by a selective near infrared fluorescence substrate-based probe
11. Short-term exposure to cigarette smoke upregulates cathepsin S and alters expression of tight junction ZO-1
12. Therapeutic targeting of cathepsin C: from pathophysiology to treatment
13. Selective inhibition of human cathepsin S by 2,4,6-trisubstituted 1,3,5-triazine analogs
14. Substrate-derived triazolo- and azapeptides as inhibitors of cathepsins K and S
15. Straightforward synthesis of 2,4,6-trisubstituted 1,3,5-triazine compounds targeting cysteine cathepsins K and S
16. Neutrophilic Cathepsin C Is Maturated by a Multistep Proteolytic Process and Secreted by Activated Cells during Inflammatory Lung Diseases
17. Antimicrobial proteins and peptides in human lung diseases: A friend and foe partnership with host proteases
18. Curcumin inhibits the TGF-β1-dependent differentiation of lung fibroblasts via PPARγ-driven upregulation of cathepsins B and L
19. The Interplay of Glycosaminoglycans and Cysteine Cathepsins in Mucopolysaccharidosis
20. Cathepsin K: both a likely biomarker and a new therapeutic target in lymphangioleiomyomatosis?
21. Regulation of TGF-β1-driven Differentiation of Human Lung Fibroblasts: EMERGING ROLES OF CATHEPSIN B AND CYSTATIN C
22. Cleavage of Occludin by Cigarette Smoke-Elicited Cathepsin S Increases Permeability of Lung Epithelial Cells
23. Specific cleavage of the lung surfactant protein A by human cathepsin S may impair its antibacterial properties
24. A yummy blend of homeostasis and proteolytic mechanisms
25. A selective reversible azapeptide inhibitor of human neutrophil proteinase 3 derived from a high affinity FRET substrate
26. Cysteine Cathepsins S and L Modulate Anti-angiogenic Activities of Human Endostatin
27. Kininogens: More than cysteine protease inhibitors and kinin precursors
28. Voltage-gated Sodium Channel Activity Promotes Cysteine Cathepsin-dependent Invasiveness and Colony Growth of Human Cancer Cells
29. Cleavage of Occludin by Cigarette Smoke-Elicited Cathepsin S Increases Permeability of Lung Epithelial Cells.
30. GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions
31. Cysteine Cathepsins: Markers and Therapy Targets in Lung Disorders
32. Lung cysteine cathepsins: Intruders or unorthodox contributors to the kallikrein–kinin system?
33. Biochemical properties and regulation of cathepsin K activity
34. Cysteine cathepsins and cystatins: from ancillary tasks to prominent status in lung diseases
35. Cystatin M/E (Cystatin 6): A Janus-Faced Cysteine Protease Inhibitor with Both Tumor-Suppressing and Tumor-Promoting Functions
36. GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions
37. Monitoring Human Neutrophil Activation by a Proteinase 3 Near-Infrared Fluorescence Substrate-Based Probe
38. Selective Inhibition of the Collagenase Activity of Cathepsin K
39. Modulation of hypotensive effects of kinins by cathepsin K
40. Cysteine cathepsins in human silicotic bronchoalveolar lavage fluids
41. Pro-angiogenic effect of human kallikrein-related peptidase 12 (KLK12) in lung endothelial cells does not depend on kinin-mediated activation of B2 receptor
42. GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions
43. Identification of parasite-responsive cysteine proteases in Manduca sexta
44. Supp_material_Bestion_et_al._review – Supplemental material for GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition
45. Regulation of cathepsin K activity by hydrogen peroxide
46. Meeting Abstract: 2143
47. Conserved cystatin segments as models for designing specific substrates and inhibitors of cysteine proteinases
48. Degradation of apolipoprotein B-100 by lysosomal cysteine cathepsins
49. Cysteine cathepsins and caspases in silicosis
50. Interaction between cystatin-derived peptides and papain
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.